Relation between Chronic Urticaria and Quality of Life: An Observational Study of 112 Portuguese Patients

Ana Rita Almeida; Bárbara Oliveiros; Margarida Gonçalo

doi:10.29021/spdv.79.3.1402

Ana Rita Almeida Interna de Formação Geral no Centro Hospitalar da Universidade de Coimbra, Coimbra, Portugal https://orcid.org/0000-0001-5308-5763
Bárbara Oliveiros Professora Doutorada, Faculdade de Medicina da Universidade de Coimbra, Portugal; Investigadora, Laboratório de Bioestatística e Informática Médica; Membro integrado de Coimbra Institute for Clinical and Biomedical Research; Colaboradora de Coimbra Institute for Biomedical Imaging and Translational Research, Coimbra, Portugal https://orcid.org/0000-0001-7836-8161
Margarida Gonçalo Assistente Hospitalar Graduada Sénior de Dermatovenereologia, Clínica Universitária de Dermatologia, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Professora Auxiliar Doutorada de Dermatologia, Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal https://orcid.org/0000-0001-6842-1360

DOI: https://doi.org/10.29021/spdv.79.3.1402

Keywords: Anxiety, Chronic Disease, Depression, Quality of Life, Surveys and Questionnaires, Urticaria

Abstract

Introduction: Chronic urticaria is a complex multifactorial dermatological disease. It is highly prevalent throughout the world and contributes to lower patients’ quality of life. The purpose of this study is to evaluate the impact of chronic urticaria on the quality of life (QoL) and mental status in Portuguese patients.

Methods: This observational study included the evaluation of Portuguese patients from the consultation of chronic urticaria in the Coimbra University Hospital Centre, using several questionnaires including: weekly urticaria activity score (UAS7), Urticaria Control Test (UCT), Dermatology Life Quality Index (DLQI), Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) and the Hospital Anxiety and Depression Scale (HADS). The results of the questionnaires were posteriorly analysed, and the quality of life and mental status assessed in these patients were correlated with sociodemographic parameters and clinical aspects of chronic urticaria.

Results: We studied 112 patients, mainly female (80%), with an average age of 46 years, mostly classified with mild urticaria activity, according to UAS7, and the majority (85%) were poorly controlled, regarding the UCT classification. Using both CU-Q2oL and DLQI we obtained mean values of 48.98 (±19.53) and 7.23 (±7.67), respectively, that show a high impact on the QoL. CU also interferes with mental status values in HADS concordant with anxiety (in a total of 45 patients) and depression (in 22 patients). A strong and positive correlation was found between both instruments used to measure quality of life, with pruritus, number of papules, quality of sleep and the embarrassment caused by cutaneous lesions as the mostly affected parameters in our sample. QoL varies significantly with gender, degree of instruction, clinical severity of symptoms and level of disease control. Although not always directly related, clinical activity of the disease remains the most significant factor of patients' QoL. Anxiety and depression show a significantly relationship with quality of life, however it was not found a significant correlation with the urticaria clinical activity.

Discussion: Patient-Reported Outcomes (PRO) proved to be a practical and effective tool in daily clinic assessment of Portuguese patients suffering from chronic urticaria. The variation of quality of life according to sociodemographic characteristics is in conformity with literature. Moreover, new results were achieved regarding the level of instruction. The mostly impaired domains in our sample’s QoL are not totally identical to previous studies, which suggests a meaningful effect of the geographic location. This investigation supported the significant influence of clinical activity of the urticaria and psychological well-being in QoL as previously published.

Conclusion: In Portuguese patients with chronic urticaria, it is essential to establish an integrated approach that encompasses the clinical control of urticaria, but also the control of the associated psychological symptomatology.

Downloads

Download data is not yet available.

References

Dreskin SC. Urticaria and Angioedema. In: Goldman-Cecil Medicine, 2-Volume Set. 25th ed. Amsterdam: Elsevier; 2018. p.1693-1698.e2

Antia C, Baquerizo K, Korman A, Bernstein J, Alikhan A. Urticaria: A comprehensive review: Epidemiology, diagnosis, and work-up. J Am Acad Dermatol. 2018;79:599–614. doi:10.1016/j.jaad.2018.01.020.

Costa C, Gonçalo M, Andrade P, Azevedo F, Barbosa M, Bastos P, et al. Abordagem Diagnóstica e Terapêutica da Urticária Crónica Espontânea: Recomendações em Portugal. Acta Med Port. 2016;29:763-81. doi: 10.20344/amp.8294.

Setia M. Medical Management of Melasma: A Review with Consensus Recommendations by Indian Pigmentary Expert Group. Indian J Dermatol. 2017;62:367–70. doi: 10.4103/ijd.IJD_489_17.

Moestrup K, Ghazanfar M, Thomsen M. Patient-reported outcomes (PROs) in chronic urticaria. Int J Dermatol. 2017;56:1342–8. doi: 10.1111/ijd.13668.

Zuberbier T, Aberer W, Asero R, Abdul Latiff A, Baker D, Ballmer-Weber B, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy Eur J Allergy Clin Immunol. 2018;73:1393–414. doi: 10.1111/all.13397.

Weller K, Zuberbier T, Maurer M. Chronic urticaria: Tools to aid the diagnosis and assessment of disease status in daily practice. J Eur Acad Dermatology Venereol. 2015;29:38–44.

Baiardini I, Braido F, Molinengo G, Caminati M, Costantino M, Cristaudo A, et al. Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice. J Allergy Clin Immunol Pract. 2018;6:208–18. doi: 10.1016/j.jaip.2017.06.023.

Ben-Shoshan M, Blinderman I, Raz A. Psychosocial factors and chronic spontaneous urticaria: a systematic review. Allergy Eur J Allergy Clin Immunol. 2013;68:131–41. doi: 10.1111/all.12068.

O'Donnell B. Urticaria: Impact on quality of life and economic cost. Immunol Allergy Clin North Am. 2014;34:89–104. doi: 10.1016/j.iac.2013.09.011.

Barbosa F, Freitas J, Barbosa A. Chronic idiopathic urticaria and anxiety symptoms. J Health Psychol. 2011;16:1038–47.

Gonçalo M, Gimenéz-Arnau A, Al-Ahmad M, Ben-Shoshan M, Bernstein J, Ensina L, et al. The global burden of chronic urticaria for the patient and society. Br J Dermatol. 2021;184:226–36. doi: 10.1111/bjd.19561.

Balp M, Vietri J, Tian H, Isherwood G. The impact of chronic urticaria from the patient’s perspective: a survey in five european countries. Patient. 2015;8:551–8.

Vietri J, Turner SJ, Tian H, Isherwood G, Balp M, Gabriel S. Effect of chronic urticaria on US patients: Analysis of the National Health and Wellness Survey. Ann Allergy, Asthma Immunol. 2015;115:306–11. doi: 10.1016/j.anai.2015.06.030.

Pasaoglu G, Bavbek S, Tugcu H, Abadoglu O, Misirligil Z. Psychological status of patients with chronic urticaria. J Dermatol. 2006;33:765–71.

Hollis K, Proctor C, McBride D, Balp M, McLeod L, Hunter S, et al. Comparison of Urticaria Activity Score Over 7 Days (UAS7) Values Obtained from Once-Daily and Twice-Daily Versions: Results from the ASSURE-CSU Study. Am J Clin Dermatol. 2018;19:267–74. doi: 10.1007/s40257-017-0331-8.

Costa C, Rosmaninho I, Guilherme A, Ferreira J, Antunes J, Pina A , et al. Chronic Urticaria in the Real-Life Clinical Practice Setting in Portugal: Baseline Results from the Non-Interventional Multicentre AWARE Study. Acta Med Port. 2019;32:133–40. doi: 10.20344/amp.9496.

Weller K, Groffik A, Church MK, Hawro T, Krause K, Metz M, et al. Development and validation of the Urticaria Control Test : A patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol. 2014;133:1365-1372.e6.

Finlay A, Khan G. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.

Baiardini I, Pasquali M, Braido F, Fumagalli F, Guerra L, Compalati E, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: Chronic urticaria quality of life questionnaire (CU-Q2oL). Allergy Eur J Allergy Clin Immunol. 2005;60:1073–8.

Ferreira P, Gonçalo M, Ferreira J, Costa C, Todo-Bom A, Abreu L, et al. Psychometric properties of the portuguese version of the chronic urticaria quality of life questionnaire (CU-Q 2 oL). Health Qual Life Outcomes. 2019;17:190. doi: 10.1186/s12955-019-1266-y.

Dias G, Pires G, Valle S, França A, Papi J, Dortas S, et al. Cross-cultural adaptation of the Brazilian-Portuguese version of the chronic urticaria quality-of-life questionnaire - CU-Q2oL. Allergy Eur J Allergy Clin Immunol. 2011;66:1487–93.

Breeman S, Cotton S, Fielding S, Jones G. Normative data for the Hospital Anxiety and Depression Scale. Qual Life Res. 2015;24:391–8.

Młynek A, Magerl M, Hanna M, Lhachimi S, Baiardini I, Canonica G, et al. The German version of the chronic urticaria quality-of-life questionnaire: Factor analysis, validation, and initial clinical findings. Allergy Eur J Allergy Clin Immunol. 2009;64:927–36.

Kocatürk E, Weller K, Martus P, Aktaş S, Kavala M, Sarigul Ş, et al. Turkish version of the Chronic urticaria quality of life questionnaire: Cultural adaptation, assessment of reliability and validity. Acta Derm Venereol. 2012;92:419–25. doi: 10.2340/00015555-1199.

Valero A, Herdman M, Bartra J, Ferrer M, Jáuregui I, Dávila I, et al. Adaptation and Validation of the Spanish Version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q 2 oL). J Investig Allergol Clin Immunol. 2008;18:426–32.

Brzoza Z, Badura-Brzoza K, Młynek A, Magerl M, Baiardini I, Canonica G, et al. Adaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL). J Dermatol Sci. 2011;62:36–41.

Lapi F, Cassano N, Pegoraro V, Cataldo N, Heiman F, Cricelli I, et al. Epidemiology of chronic spontaneous urticaria: results from a nationwide, population-based study in Italy. Br J Dermatol. 2016;174:996–1004. doi: 10.1111/bjd.14470.

Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol. 2010;35:869–73.

Dias G, Pires G, do Valle S, Dortas Júnior S, Levy S, França A, et al. Impact of chronic urticaria on the quality of life of patients followed up at a university hospital. An Bras Dermatol. 2016;91:754–9.

Caballero T, Prior N. Burden of Illness and Quality-of-Life Measures in Angioedema Conditions. Immunol Allergy Clin North Am. 2017;37:597–616. doi: 10.1016/j.iac.2017.04.005.

Cavariani Silvares M, Parise Fortes M, Miot H. Quality of life in chronic urticaria: a survey at a public university outpatient clinic, Botucatu (Brazil). Rev Assoc Med Bras. 2011;57:577–82.

Tat TS. Higher Levels of Depression and Anxiety in Patients with Chronic Urticaria. Med Sci Monit. 2019;25:115–20.

Ferrer M, Bartra J, Giménez-Arnau A, Jauregui I, Labrador-Horrillo M, Ortiz de Frutos J, et al. Management of urticaria: not too complicated, not too simple. Clin Exp Allergy. 2015;45:731–43.

Saini S, Kaplan A. Chronic Spontaneous Urticaria: The Devil’s Itch. J Allergy Clin Immunol Pract. 2018;6:1097–106. doi: 10.1016/j.jaip.2018.04.013.

Weller K, Siebenhaar F, Hawro T, Altrichter S, Schoepke N, Maurer M. Clinical Measures of Chronic Urticaria. Immunol Allergy Clin North Am. 2017;37:35–49. doi: 10.1016/j.iac.2016.08.005.